Introduction
Professor Ye Dingwei (叶定伟) is the Chief of Urology at Fudan University Shanghai Cancer Center (FUSCC) — China's most prestigious cancer center. With decades of clinical experience and a distinguished record in urologic oncology, Professor Ye is widely recognized as one of China's foremost experts in prostate cancer, bladder cancer, kidney cancer, and complex urologic oncology surgery. His expertise spans the full spectrum of urologic cancer surgery, with particular distinction in radical prostatectomy, radical cystectomy with urinary diversion, nephrectomy, and minimally invasive urologic surgery. International patients seeking expert urologic cancer surgery in Shanghai consistently regard Professor Ye as a premier choice.
Academic Distinctions & Leadership
- Chief of Urology, Fudan University Shanghai Cancer Center (FUSCC)
- Professor of Urology, Fudan University Shanghai Medical College
- Director, Urology Department, Fudan University Shanghai Cancer Center
- Member, Chinese Urological Association
- Prostate Cancer Committee Member, Chinese Anti-Cancer Association
- Member, Chinese Medical Association, Urology Branch
- Editorial Board Member, multiple Chinese and international urology journals
- Recipient, multiple national and Shanghai municipal science and technology awards
- Visiting fellow at leading urologic oncology centers internationally
Specializations & Expertise
Prostate Cancer Surgery
- Radical prostatectomy (open, laparoscopic, robotic-assisted)
- Nerve-sparing radical prostatectomy for potency preservation
- Extended pelvic lymph node dissection
- Salvage prostatectomy after radiation failure
- Surgery for locally advanced prostate cancer
- Management of biochemical recurrence after surgery
Bladder Cancer Surgery
- Transurethral resection of bladder tumor (TURBT)
- Radical cystectomy with urinary diversion
- Orthotopic neobladder reconstruction
- Ileal conduit urinary diversion
- Continent cutaneous urinary diversion
- Laparoscopic and robotic radical cystectomy
- Bladder-sparing multimodal treatment coordination
Kidney Cancer Surgery
- Radical nephrectomy (open, laparoscopic, robotic)
- Partial nephrectomy (nephron-sparing surgery)
- Robotic partial nephrectomy
- Surgery for locally advanced renal cell carcinoma
- Inferior vena cava tumor thrombus surgery
- Adrenalectomy for adrenal tumors
Other Urologic Cancers
- Testicular cancer surgery (radical orchiectomy, retroperitoneal lymph node dissection)
- Penile cancer surgery
- Upper tract urothelial carcinoma (nephroureterectomy)
- Adrenal cancer surgery
Minimally Invasive Urologic Surgery
- Laparoscopic urologic oncology surgery
- Robotic-assisted urologic surgery (da Vinci system)
- Single-port laparoscopic surgery
Clinical Excellence & Innovation
Professor Ye Dingwei has performed thousands of urologic oncology surgeries throughout his distinguished career, with outcomes consistently meeting or exceeding international benchmarks. FUSCC's Urology Department under his leadership is one of the highest-volume urologic oncology programs in China.
- Prostate Cancer Leadership: One of China's leading experts in radical prostatectomy, with extensive experience in nerve-sparing techniques for preservation of urinary continence and sexual function
- Bladder Reconstruction Innovation: Advanced orthotopic neobladder reconstruction techniques providing patients with natural voiding after radical cystectomy
- Robotic Surgery Pioneer: Extensive experience with robotic-assisted urologic surgery, achieving excellent oncological outcomes with reduced surgical trauma
- Complex Renal Surgery: Specialized expertise in partial nephrectomy for kidney cancer, preserving renal function while achieving complete tumor removal
- IVC Thrombus Surgery: Advanced surgical techniques for renal cell carcinoma with inferior vena cava tumor thrombus extension
Research & Academic Contributions
Professor Ye is one of China's most prolific urologic oncology researchers with numerous peer-reviewed publications in leading Chinese and international urology journals including European Urology, Journal of Urology, and BJU International. His research focuses on prostate cancer surgical outcomes, bladder cancer management, kidney cancer surgery, and minimally invasive urologic oncology.
Major research contributions include:
- Oncological and functional outcomes of nerve-sparing radical prostatectomy
- Orthotopic neobladder reconstruction outcomes and quality of life
- Robotic versus laparoscopic radical prostatectomy outcomes
- Partial nephrectomy for complex renal tumors
- Surgical management of renal cell carcinoma with IVC thrombus
Hospital Affiliation
Fudan University Shanghai Cancer Center (FUSCC)
270 Dongan Road, Xuhui District, Shanghai 200032
Fudan University Shanghai Cancer Center is China's most prestigious and comprehensive cancer center. The Urology Department is one of the highest-volume urologic oncology programs in China, featuring:
- High-volume urologic oncology surgery program
- State-of-the-art robotic surgery system (da Vinci)
- Multidisciplinary urologic oncology team (MDT) including medical oncologists, radiation oncologists, and pathologists
- Advanced urologic imaging (MRI, CT, PET-CT, PSMA PET)
- Comprehensive prostate cancer program including active surveillance
- Bladder cancer program with bladder-sparing options
- Urodynamics and continence rehabilitation program
- International patient services with English-speaking coordinators
Patient Care Philosophy
- Oncological Safety First: Complete cancer removal is the primary goal of every surgical plan
- Function Preservation: Strong commitment to preserving urinary continence and sexual function through nerve-sparing techniques when oncologically safe
- Minimally Invasive When Appropriate: Preference for laparoscopic and robotic approaches to reduce surgical trauma and accelerate recovery
- Multidisciplinary Approach: All cases reviewed by a comprehensive MDT before treatment decisions
- Evidence-Based Practice: All decisions guided by the latest international urologic oncology guidelines (EAU, AUA, NCCN)
- Quality of Life Focus: Committed to minimizing the impact of cancer surgery on long-term quality of life
Why Choose Professor Ye Dingwei?
- China's Premier Cancer Center: Fudan University Shanghai Cancer Center — highest-volume and most respected cancer center in China
- Prostate Cancer Authority: One of China's foremost experts in radical prostatectomy with nerve-sparing techniques
- Bladder Reconstruction Expert: Advanced neobladder reconstruction for natural voiding after cystectomy
- Robotic Surgery Expertise: Extensive robotic urologic surgery experience
- Comprehensive MDT: Every case reviewed by China's top urologic oncology multidisciplinary team
- Cost-Effective Excellence: Urologic cancer surgery costs in Shanghai are typically 60-80% lower than in the US or Europe
- Proven International Track Record: Trusted by patients from around the world
Conditions Treated
Prostate Conditions
- Prostate cancer (all stages)
- High-risk localized prostate cancer
- Locally advanced prostate cancer
- Biochemical recurrence after prior treatment
Bladder Conditions
- Non-muscle-invasive bladder cancer
- Muscle-invasive bladder cancer
- Locally advanced bladder cancer
- Urothelial carcinoma
Kidney Conditions
- Renal cell carcinoma (all subtypes)
- Complex renal tumors requiring partial nephrectomy
- Renal cancer with IVC thrombus
- Adrenal tumors
Other Urologic Cancers
- Testicular cancer
- Upper tract urothelial carcinoma
- Penile cancer
International Patient Services
China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking urologic cancer surgery with Professor Ye Dingwei at Fudan University Shanghai Cancer Center.
Pre-Arrival Support
- Medical Record Review: Review of your pathology, PSA results, imaging (MRI, CT, bone scan, PSMA PET), and staging workup
- Virtual Consultation: Video consultation with Professor Ye's team to discuss your diagnosis and surgical options
- MDT Review: Arrangement of multidisciplinary team review of your case
- Treatment Planning: Personalized surgical plan including approach, nerve-sparing options, and reconstruction choices
- Second Opinion Service: Expert second opinion on diagnosis and treatment plan
- Cost Transparency: Detailed cost estimate including consultations, surgery, and hospitalization
- Visa Assistance: Medical visa guidance and invitation letters
- Travel Arrangements: Flights, airport pickup, and accommodation near the hospital
During Treatment
- Professional Medical Interpretation: Experienced urology interpreters at all appointments and procedures
- Hospital Navigation Support: Registration, payment, and hospital navigation assistance
- Pre-operative Testing: Coordination of additional imaging, biopsy, and staging workup as needed
- Surgical Support: Accompaniment and family support on surgery day
- 24/7 Support: Round-the-clock assistance for any concerns
Post-Treatment Care
- Pathology Report Translation: Complete translation of surgical pathology reports
- Treatment Summary: Comprehensive oncology summary for your home urologist and oncologist
- Continence Rehabilitation: Guidance on pelvic floor exercises and continence recovery after prostatectomy
- Adjuvant Therapy Coordination: Guidance on recommended radiation, hormonal therapy, or systemic therapy
- Telemedicine Follow-up: Virtual follow-up with Professor Ye's team
- Long-term Support: Ongoing assistance for PSA monitoring and surveillance after returning home
Schedule Your Consultation
If you or a loved one has been diagnosed with prostate cancer, bladder cancer, kidney cancer, or another urologic malignancy, Professor Ye Dingwei at Fudan University Shanghai Cancer Center offers world-class urologic oncology surgical expertise at a fraction of Western costs.
Contact China Medical Concierge - Shanghai today to request a pathology and imaging review, schedule a virtual consultation, and begin planning your journey to Shanghai for expert urologic cancer surgery.
Bridging international patients with Shanghai's finest urologic oncology surgeons — because your cancer care deserves the expertise of China's most experienced urologic oncology team.
0 commentaire